710 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Ledyard National Bank

Ledyard National Bank purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 710 shares of the pharmaceutical company’s stock, valued at approximately $250,000. Several other institutional investors and hedge funds […]

Related Keywords

Sangeetan Bhatia ,Brucei Sachs , ,Grove Bank ,Barclays ,Paradigm Financial Partners ,Vertex Pharmaceuticals ,Davidson Capital Management Inc ,Securities Exchange Commission ,Wells Fargo Company ,Grandfield Dodd ,Parkside Financial Bank ,Vertex Pharmaceuticals Stock Performance ,News Ratings For Vertex Pharmaceuticals Daily ,Ledyard National Bank ,Canaccord Genuity Group ,Morgan Stanley ,Vertex Pharmaceuticals Incorporated ,Vertex Pharmaceuticals Profile ,Quarter For Vertex Pharmaceuticals ,Free Report ,Financial Partners ,Capital Management ,Financial Bank ,Director Bruce ,Exchange Commission ,Director Sangeeta ,Pharmaceuticals Incorporated ,Get Free Report ,Genuity Group ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,